Asymmetrically substituted antrapyridazone derivatives used as cytostatics modulating multidrug resistance of tumor cells

The invention relates to the new, asymmetrically substituted derivatives of 2,7-dihydro-3H-dibenzo[de,h]cinnoline-3,7-dione and their use as cytostatics exhibiting activity against tumor cells, especially against cells with multidrug resistance (MDR). In particular, the invention concerns derivative...

Full description

Saved in:
Bibliographic Details
Main Authors BONTEMPS-GRACZ MARIA, WYSOCKA MALGORZATA, WIETRZYK JOANNA, MAZERSKI JAN, PUNDA PAWEL, BOROWSKI EDWARD, DZIEDUSZYCKA MARIA, STEFANSKA BARBARA, SZELEJEWSKI WIESLAW, OBUKOWICZ JANUSZ, CYBULSKI MARCIN
Format Patent
LanguageEnglish
Polish
Published 22.10.2012
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The invention relates to the new, asymmetrically substituted derivatives of 2,7-dihydro-3H-dibenzo[de,h]cinnoline-3,7-dione and their use as cytostatics exhibiting activity against tumor cells, especially against cells with multidrug resistance (MDR). In particular, the invention concerns derivatives of 2,7-dihydro-3H-dibenzo[de,h]cinnoline-3,7-dione represented by the general formula (I).
Bibliography:Application Number: PL20110394569